Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a26e7152ffc5a87d

Jump to content

Talk:Combretastatin A-4

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 14 years ago by Edgar181 in topic List of references

List of references

[edit]

The following list of references was added to the article, but apparently are not used to support specific content in the article. I'm moving them here in case anyone would like to use them to expand this article. -- Ed (Edgar181) 19:17, 16 August 2011 (UTC)Reply

  • Nam, N. Combretastatin A-4 Analogues as Antimitotic Antitumor Agents Current Medicinal Chemistry, 2003, 10, 1697-1722.
  • Griggs, J; Metcalfe, J. C; Hesketh, R. Targeting tumor vasculature: the development of combretastatin A4 Lancet Oncol, 2001, 2, 82-87.
  • Hori, K; Saito, S. Microvascular Mechanisms by which the Combretastatin A-4 Derivative AC7700 (AVE8062) Induces Tumor Blood Flow Stasis British Journal of Cancer, 2003, 89, 1334-1344.
  • Mukund K. Gurjar, “Synthesis and Evaluation of 4/5-Hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-Restricted Analogues of Combretastatin A-4 as Novel Anticancer Agents” J. Med. Chem. 2007, 50, 1744-1753
  • Tron, G; Pirali, T; Sorba, G; Pagliai, F; Busacca, S; Genazzani, A. Medicinal Chemistry of Combretastatin A4: Present and Future Directions Journal of Medicinal Chemistry, 2006, 49, 3033-3044.
  • Pandit, Bulbul; Sun, Yanjun; Chen, Ping; Sackett, Dan; Hu, Zhigen; et al. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416 Bioorganic and Medicinal Chem, 2006, 14, 6492-6501
  • Hamze, A. ; Rasolofonjatovo, E. ; Provot, O. ; Mousset, C. ; Veau, D. ; Rodrigo, J. ; Bignon, J. ; J-M Liu. ; Wdzieczak-Bakala, J. ; Thoret, S. ; Dubois, J. ; Brion, J.-D. ; Alami, M. B-Ring-Modified isoCombretastatin A-4 Analogues Endowed with Interesting Anticancer Activities. ChemMedChem 2011, 6, 2179-2191. doi:10.1002/cmdc.201100325